Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home
  
Scientific News
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Can Cell Cycle Protein Prevent or Kill Breast Cancer Tumors?
An MD Anderson study has shown the potential of a simple molecule involved in cancer metabolism as a powerful therapeutic.
Study Reveals Improved Way to Interpret High-Throughput Biological Data
A recent study has revealed a novel workflow, identifying associations between molecules to provide insights into cellular metabolism and gene expression in complex biological systems.
Optical 'Dog's Nose' Developed to Detect Cancer, Other Diseases
Researchers are using optical spectroscopy to develop a quick, non-invasive “breath test” they believe will have the potential to screen for a variety of diseases, including diabetes, infections and cancers.
Researchers Link Liver Disease and Drug Metabolism
Researchers have discovered that nonalcoholic steatohepatitis, an increasingly common but often undiagnosed liver disease, could have significant medical implications for people with type 2 diabetes.
Scientists Create Synthetic Membranes That Grow Like Living Cells
Chemists and biologists at UC San Diego have succeeded in designing and synthesizing an artificial cell membrane capable of sustaining continual growth, just like a living cell.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Team Led by TSRI Scientists Shows AIDS Vaccine Candidate Successfully ‘Primes’ Immune System
New research shows that an experimental vaccine candidate can stimulate immune activity necessary to prevent HIV infection.
The Perfect Partnership: Research & Industry; Software & Instrumentation. It really starts to come together at ASMS 2015
Collaboration and knowledge-sharing were evident everywhere: on the bus, in the hallways and in the bars. This article aims to capture this theme and share with you some of the fruits of this coming together of science and industry.

Life Science Consumables 2013: Markets and Opportunities
Bookmark and Share

Biopharm Reports has carried out six studies in the life science field, which examined the use of consumables in the conduct of PCR, DNA sequencing, DNA microarray, flow cytometry, mass spectrometry and disease biomarker studies. These studies, which involved the participation of more than 2200 end-users in 70 countries, were carried out to assist developers and vendors of consumables to identify market opportunities in these fields.

This Report Provides:

• Consumables : A breakdown of end-user practices in the use of consumables in the conduct of PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry and disease biomarker studies.

• Fields: A breakdown of end-user practices in the use of consumables by field (biotechnology, chemicals, clinical or hospital, defence, diagnostics, energy, environmental, food and drink, forensics, geology, government, healthcare, natural products, pharmaceuticals, research institutes, security and university) in the conduct of PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry and disease biomarker studies.

• Regions: A breakdown of end-user practices in the use of consumables by region (Europe, North America, Asia and Rest of World) in the conduct of PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry and disease biomarker studies.

• Growth: A listing of organisations of participants in the PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry and disease biomarker studies described in this report, according to anticipated growth in these areas, (i.e. decline in activities, activities remain the same or increase in activities).

• Market Sizes: Estimates of global markets sizes of consumables used in the PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry and disease biomarker fields. These estimates are based on published market sizes of these fields, and the present study findings described in this report.

Key Areas

• PCR (Participants, n=614): Disclosures by experienced PCR end-users on their top three consumables in terms of costs, in the PCR field; end-users' estimates of the breakdown of their current and future (2012 - 2015) annual budgets in percentage terms across eight general areas, including consumables, in the PCR field.

• DNA Microarray (Participants, n=201): Disclosures by experienced DNA microarray end-users on their top three consumables in terms of costs, in the DNA microarray field; End-users' estimates of the breakdown of their current and future (2012 - 2015) annual budgets in percentage terms across eight general areas, including consumables, in the DNA microarray field.

• DNA Sequencing (Participants, n=108): Disclosures by experienced DNA sequencers on their top three consumables in terms of costs, in the DNA sequencing field; end-users' estimates of the breakdown of their current and future (2012 - 2015) annual budgets in percentage terms across eight general areas, including consumables, in the DNA sequencing field.

• Flow Cytometry (Participants, n=262): Disclosures by experienced flow cytometry end-users on their top two reagents and consumables in terms of costs, in the flow cytometry field; end-users' estimates of the breakdown of their current annual budgets in percentage terms across nine general areas, including reagents and consumables, in the flow cytometry field.

• Mass Spectrometry (Participants, n=567): Disclosures by experienced mass spectrometry end-users on their top three consumables in terms of costs, in the mass spectrometry; End-users' estimates of the breakdown of their current annual budgets in percentage terms across four general areas, including consumables, in the mass spectrometry field.

• Disease Biomarkers (Participants n=511): End-users' estimates of the breakdown of their current annual budgets in percentage terms across six general areas, including consumables, in the disease biomarker field.

• Participant Organisations: The names, countries and application areas of participant organisations

• Organisation Growth Trends: Organisations' reported plans in terms of growth in the area to which the software and databases relate (i.e. decline in activities, activities remain the same or increase in activities).



Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!